Iron Dysregulation in Alzheimer’s Disease: LA-ICP-MS Bioimaging of the Distribution of Iron and Ferroportin in the CA1 Region of the Human Hippocampus

  1. Junceda, Susana 234
  2. Cruz-Alonso, María 1
  3. Fernandez, Beatriz 1
  4. Pereiro, Rosario 1
  5. Martínez-Pinilla, Eva 345
  6. Navarro, Ana 345
  1. 1 Department of Physical and Analytical Chemistry, Faculty of Chemistry, University of Oviedo, Julian Claveria 8, 33006 Oviedo, Spain
  2. 2 Servicio de Anatomo-Patología, Hospital Universitario Central de Asturias–HUCA, Av Roma s/n, 33011 Oviedo, Spain
  3. 3 Instituto de Neurociencias del Principado de Asturias (INEUROPA), 33006 Oviedo, Spain
  4. 4 Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain
  5. 5 Department of Morphology and Cell Biology, Faculty of Medicine, University of Oviedo, Julian Claveria 6, 33006 Oviedo, Spain
Erakutsi afiliazioak +
Aldizkaria:
Biomolecules

ISSN: 2218-273X

Argitalpen urtea: 2024

Alea: 14

Zenbakia: 3

Orrialdeak: 295

Mota: Artikulua

DOI: 10.3390/BIOM14030295 GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Biomolecules

Garapen Iraunkorreko Helburuak

€ Ikusi finantzaketa

Finantzaketari buruzko informazioa

Finantzatzaile

Erreferentzia bibliografikoak

  • Lei, P., Ayton, S., and Bush, A.I. (2021). The Essential Elements of Alzheimer’s Disease. J. Biol. Chem., 296.
  • Chen, (2016), F1000Research, 5, pp. 1, 10.12688/f1000research.7431.1
  • Santos, (2016), Oxid. Med. Cell. Longev., 2016, pp. 9812178
  • Raha, (2013), Acta Neuropathol. Commun., 1, pp. 55, 10.1186/2051-5960-1-55
  • Bandyopadhyay, (2014), Biochem. Pharmacol., 88, pp. 486, 10.1016/j.bcp.2014.01.032
  • Carocci, (2018), BioMetals, 31, pp. 715, 10.1007/s10534-018-0126-2
  • Connor, (1992), J. Neurosci. Res., 31, pp. 327, 10.1002/jnr.490310214
  • Peters, (2015), Neurobiol. Dis., 81, pp. 49, 10.1016/j.nbd.2015.08.007
  • Wang, (2019), Advances in Experimental Medicine and Biology, Volume 1173, pp. 67, 10.1007/978-981-13-9589-5_5
  • Nabuurs, (2013), J. Histochem. Cytochem., 61, pp. 785, 10.1369/0022155413501325
  • Bulk, (2017), J. Alzheimers Dis., 60, pp. 1533, 10.3233/JAD-161143
  • Meguro, (2007), Arch. Histol. Cytol., 70, pp. 1, 10.1679/aohc.70.1
  • Meguro, (2003), Histochem. Cell Biol., 120, pp. 73, 10.1007/s00418-003-0539-y
  • Fernandez, (2018), Anal. Chem., 90, pp. 12145, 10.1021/acs.analchem.8b03124
  • Fernandez, (2019), Talanta, 197, pp. 413, 10.1016/j.talanta.2019.01.056
  • Braak, (1991), Acta Neuropathol., 82, pp. 239, 10.1007/BF00308809
  • Navarro, (2015), Acta Histochem., 117, pp. 536, 10.1016/j.acthis.2015.04.003
  • Tolivia, (1994), Histochemistry, 102, pp. 101, 10.1007/BF00269013
  • Reusche, (1991), Pathol. Res. Pract., 187, pp. 1045, 10.1016/S0344-0338(11)81084-8
  • Navarro, (1999), J. Histotechnol., 22, pp. 305, 10.1179/his.1999.22.4.305
  • Navarro, (2013), J. Alzheimers Dis., 35, pp. 589, 10.3233/JAD-122386
  • (2015), Eur. J. Histochem., 59, pp. 2485
  • He, D., Li, T., Yang, X., Xu, Y., and Sun, H. (2023). Sudan Black B Treatment for Reducing Autofluorescence in Human Glioma Tissue and Improving Fluorescent Signals of Bacterial LPS Staining. J. Biophotonics, 16.
  • Luo, (2014), Chem. Commun., 50, pp. 5143, 10.1039/C3CC47512C
  • Khan, (2022), Talanta, 241, pp. 123228, 10.1016/j.talanta.2022.123228
  • Arribarat, (2019), Front. Neuroanat., 13, pp. 68, 10.3389/fnana.2019.00068
  • Uchida, (2022), Front. Neurosci., 16, pp. 938092, 10.3389/fnins.2022.938092
  • Van Oostveen, W.M., and de Lange, E.C.M. (2021). Imaging Techniques in Alzheimer’s Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring. Int. J. Mol. Sci., 22.
  • Bulk, (2020), Neuroimage, 215, pp. 116808, 10.1016/j.neuroimage.2020.116808
  • Ayton, (2020), Mol. Psychiatry, 25, pp. 2932, 10.1038/s41380-019-0375-7
  • Falangola, (2005), Neurochem. Res., 30, pp. 201, 10.1007/s11064-004-2442-x
  • Meguro, (2008), Arch. Histol. Cytol., 71, pp. 205, 10.1679/aohc.71.205
  • Nikparast, (2022), Insights Imaging, 13, pp. 74, 10.1186/s13244-022-01207-6
  • Ayton, (2017), Brain, 140, pp. 2112, 10.1093/brain/awx137
  • Spotorno, (2020), Brain, 143, pp. 1341, 10.1093/brain/awaa089
  • Cogswell, (2023), Neuroimage, 273, pp. 120068, 10.1016/j.neuroimage.2023.120068
  • Cogswell, (2021), Neuroimage, 224, pp. 117433, 10.1016/j.neuroimage.2020.117433
  • Hare, (2016), Neuroimage, 137, pp. 124, 10.1016/j.neuroimage.2016.05.057
  • Qian, (2019), Biol. Rev., 94, pp. 1672, 10.1111/brv.12521
  • Zhao, (2015), Cell, 163, pp. 1064, 10.1016/j.cell.2015.10.067
  • Raha, A.A., Biswas, A., Henderson, J., Chakraborty, S., Holland, A., Friedland, R.P., Mukaetova-Ladinska, E., Zaman, S., and Raha-Chowdhury, R. (2022). Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer’s, and Parkinson’s Diseases. Int. J. Mol. Sci., 23.
  • Bao, (2021), Cell Death Differ., 28, pp. 1548, 10.1038/s41418-020-00685-9
  • Zlokovic, (2011), Nat. Rev. Neurosci., 12, pp. 723, 10.1038/nrn3114
  • Montagne, (2017), J. Exp. Med., 214, pp. 3151, 10.1084/jem.20171406